wehale.life for healthcare professionals

Dear Healthcare Professional,

Welcome to Wehale.life - website about asthma and COPD (chronic obstructive pulmonary disease). This section is intended for healthcare professionals treating people with respiratory conditions. Depending on the country you might have to register to get access.
Choose your local article below - or scroll down to choose your country. Read more about wehale.life content for Healthcare Professionals


Events
en
ERS 2020 - sign up materials

ERS 2020 - sign up materials

The international respiratory community gathered together to share the latest scientific data & findings on respiratory medicine at the ERS congress in September. Sign up here if you wish to receive access to the recordings and symposium review article.

Insights
sv
Single-inhaler combination therapy in bronchial asthma – real-world data from daily clinical practice

Single-inhaler combination therapy in bronchial asthma – real-world data from daily clinical practice

Real-world studies can provide valuable information on patient experience and satisfaction with the inhaler, as well as on clinical efficacy and adherence to inhaled treatment in daily use. Read about the efficacy of combination therapy in bronchial asthma as evaluated in a Polish real-world study.

Insights
pl
Terapia wziewna – ze szczególnym uwzględnieniem steroidów – w okresie pandemii COVID-19

Terapia wziewna – ze szczególnym uwzględnieniem steroidów – w okresie pandemii COVID-19

Insights
es
Cercano al inhalador ideal: fácil y conveniente

Cercano al inhalador ideal: fácil y conveniente

Para cumplir con el concepto de un inhalador "ideal", el dispositivo debe albergar una serie de características entre las que se encuentran ser efectivo, cómodo, versátil y ecológico.

Insights
nl-BE
Inhaler-switch in real-world clinical practice – impact on clinical outcomes and QoL

Inhaler-switch in real-world clinical practice – impact on clinical outcomes and QoL

Real-world studies are essential in comparing different inhalers in daily use and assessing the grounds of poor asthma and COPD control. How does inhaler switch affect patient satisfaction and disease control in real-world clinical practice? Explore the real-world results.

Insights
da
Challenging inhaler performance with simulated real-world conditions

Challenging inhaler performance with simulated real-world conditions

It is essential that an inhaler maintains its performance even when exposed to environmental stress conditions such as varying temperature, humidity and dropping. Read about the performance of Orion’s DPI under simulated real-world conditions.

Insights
nl-BE
Addressing pharmacokinetic bioequivalence of combination therapy – comparison of different dry powder inhalers

Addressing pharmacokinetic bioequivalence of combination therapy – comparison of different dry powder inhalers

Pharmacokinetic measures of lung deposition and systemic exposure of medication can help to evaluate and compare the efficacy and safety of inhaled therapy with different inhalers. Read more about pharmacokinetic bioequivalence study of Orion’s DPI and the originator product.

Insights
fi
Potilaiden tyytyväisyys inhalaattoriin on yhteydessä parempaan hoitomyöntyvyyteen ja astman hoitotasapainoon

Potilaiden tyytyväisyys inhalaattoriin on yhteydessä parempaan hoitomyöntyvyyteen ja astman hoitotasapainoon

Tutkimuksen mukaan kuivajauheinhalaattoria käyttävät potilaat olivat huomattavasti tyytyväisempiä hoitoonsa kuin ponnekaasuaerosolia käyttävät potilaat.

Aktuelles
de
www.wehale.life/de/Corona/

www.wehale.life/de/Corona/

Informationen zum umgang mit asthma und COPD in coronazeiten


Wehale.life content for healthcare professionals is available for prescribing doctors in the following countries:

CLICK YOUR COUNTRY TO LOG IN

Belgium Belgium - French - Dutch
 
Denmark Denmark
 
Germany Germany
 
Finland Finland
 
Poland Poland
 
Spain Spain
 
Sweden Sweden
 
United Kingdom United Kingdom

Dear Healthcare Professional, 

Asthma, Chronic Obstructive Pulmonary Disease (COPD) and people suffering from these conditions are close to our heart at Orion Pharma. That is why we want to support your daily work by delivering: 

  • The latest news from scientific world in these therapy areas  
  • “How-to” videos and other patient support materials  
  • Information about Orion Pharma’s products, services and educational events  

*Required information to process this request.

By submitting your personal details, you give your consent to Orion Corporation and its affiliates (see list here) to process your personal data for the purposes of electronic direct marketing.


Orion Corporation | Orionintie 1A, FI-02200 Espoo, Finland | Tel. +358 10 4261
Wehale.Life Contact us Orion Corporation 2020